2025-21501NoticeWallet

Medicare Starts Bargaining for Cheaper Wonder Drugs

Published Date: 11/28/2025

Notice

Summary

Starting in 2026, Medicare will negotiate lower prices for some expensive drugs to help save money for patients and the government. This new rule affects drug makers, who must follow price limits through 2028, including a first-ever renegotiation cycle. These changes aim to make medicines more affordable while protecting certain special drugs, with clear deadlines and rules set by CMS.

Analyzed Economic Effects

1 provisions identified: 1 benefits, 0 costs, 0 mixed.

Medicare drug price negotiations 2026–2028

If you have Medicare, CMS will negotiate lower maximum fair prices for certain high‑cost, single‑source drugs starting in 2026. The final guidance covers manufacturer effectuation of those maximum fair prices in 2026, 2027, and 2028 and implements the Initial Price Applicability Year (IPAY) 2028 from January 1, 2028 to December 31, 2028; CMS also notes expanded protections for orphan drugs under the July 4, 2025 law change.

Your PRIA Score

Score Hidden

Personalized for You

How does this regulation affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Key Dates

Published Date
Effective Date
11/28/2025
1/1/2026

Department and Agencies

Department
Independent Agency
Agency
Health and Human Services Department
Centers for Medicare & Medicaid Services
Source: View HTML

Related Federal Register Documents

Previous / Next Documents

Back to Federal Register

Take It Personal

Get Your Personalized Policy View

Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.

Already have an account? Sign in